Standard and reference-based conditional mean imputation.

Authors:
Wolbers M; Noci A; Delmar P; Gower-Page C; Yiu S and 1 more

Journal:
Pharm Stat

Publication Year: 2022

DOI:
10.1002/pst.2234

PMCID:
PMC9790242

PMID:
35587109

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Pharm Stat

Abbreviation: Pharm Stat

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Statistics as Topic

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
CUSUMIN: A cumulative sum interval design for cancer phase I dose finding studies.
Hatayama T; Yasui S. (2022) - Transparency Score: 2/6
Decision rules for identifying combination therapies in open-entry, randomized controlled platform …
Meyer EL; Mesenbrink P; Dunger-Baldauf C and 4 more (2022) - Transparency Score: 4/6
Incorporating historical controls in clinical trials with longitudinal outcomes using the modified …
Qi H; Rizopoulos D; Lesaffre E and 1 more (2022) - Transparency Score: 2/6
Pairwise joint modeling of clustered and high-dimensional outcomes with covariate missingness in pe…
Gachau S; Njagi EN; Molenberghs G and 4 more (2022) - Transparency Score: 3/6
Should the two-trial paradigm still be the gold standard in drug assessment?
Zhan SJ; Kunz CU; Stallard N. (2022) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Evidence found in paper:

"all simulation code has been uploaded to github and can be found at https://github com/nociale/simulation_condmean_manuscript ."

Evidence found in paper:

"CONFLICT OF INTEREST Bartlett's institution has received consultancy fees for the author's advice on statistical methodology from AstraZeneca, Bayer, Novartis, and Roche. Bartlett has received consultancy and course fees from Bayer and Roche."

Evidence found in paper:

"Funding information Medical Research Council, Grant/Award Number: MR/T023953/1"

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025